Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02728 |
| Species: | Homo sapiens |
| Position : | chr20:61300000-61600000 |
| Year: | 2024 |
| Title: | Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | breast cancer |
| PMID: | 39277592 |
| MONDO: | MONDO:0007254 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | REC-1 |
| CVCL ID: | CVCL_1884 |
| Cell Type: | B cell |
| Cell Ontology ID: | CL:0000236 |
| Experiment Type: | Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | Hi-C, ATAC-seq, H3K27ac ChIP-seq, RNA-seq |
| Low Throughput Method: | RT-RT-qPCR |
| Target gene : | BCL2L1 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|